New guidelines for the clinical management of febrile neutropenia and sepsis in pediatric oncology patients

被引:0
|
作者
Almeida Mendes, Ana Verena [1 ,2 ]
Sapolnik, Roberto [3 ]
Mendonca, Nubia [4 ]
机构
[1] Univ Sao Paulo, Sao Paulo, SP, Brazil
[2] Escola Bahiana Med & Saude Publ, Salvador, BA, Brazil
[3] Univ Fed Bahia, Salvador, BA, Brazil
[4] Sociedade Oncol Bahia ONCO, Ser Oncol Pediat, Salvador, BA, Brazil
关键词
D O I
10.2223/JPED.1624
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Objectives: To provide a foundation for the diagnostic, prophylactic and therapeutic management of febrile neutropenia and sepsis in children with oncological diseases, with special attention to new protocols and guidelines. Sources: A review of the scientific literature utilizing an electronic bibliographic search on MEDLINE, Medscape, SciELO, Google, Cochrane and PubMED using the keywords febrile, neutropenic, cancer, children, sepsis, intensive, care. Articles published between 1987 and 2007 were selected, with preference given to review articles, protocols, systematic reviews, epidemiological studies, task force recommendations and phase III clinical trials. Consensus documents published by the Infectious Diseases Society of America, the Center for Diseases Control and the Infectious Diseases Working Party of the German Society of Hematology and Oncology, in addition to the recommendations of the World Federation of Pediatric Intensive and Critical Care Societies and Society of Critical Care Medicine, were also reviewed. Summary of the findings: The use of aggressive chemotherapy regimens, bone marrow transplantation and intensive care resources have increased the survival rates of children with cancer and also their infectious morbidity, with septic complications as the principal cause of mortality. Several risk factors have been identified, such as neutropenia, oncology type, clinical signs and inflammatory response markers (polymerase chain reaction, procalcitonin) and also increased resistance to antimicrobials and antifungal agents. Protocols for risk classification, diagnosis and treatment should be established at each service, taking into account the microbiological flora of each population. Pediatric intensive care has increased the short and long-term survival of these patients. Conclusions: Oncology patients are particularly vulnerable to infectious complications. Early identification and treatment are fundamental to improving survival rates.
引用
收藏
页码:S54 / S63
页数:10
相关论文
共 50 条
  • [41] Risk-stratification management of febrile neutropenia in pediatric hematology-oncology patients: Results of a French nationwide survey
    Delebarre, Mathilde
    Tiphaine, Aude
    Martinot, Alain
    Dubos, Francois
    [J]. PEDIATRIC BLOOD & CANCER, 2016, 63 (12) : 2167 - 2172
  • [42] Outpatient versus inpatient IV antibiotic management for pediatric oncology patients with low risk febrile neutropenia: A randomised trial
    Jospeh L. Mathew
    Ramandeep Singh Arora
    Janani Sankar
    [J]. Indian Pediatrics, 2014, 51 : 659 - 661
  • [43] Outpatient versus inpatient IV antibiotic management for pediatric oncology patients with low risk febrile neutropenia: A randomised trial
    Mathew, Jospeh L.
    [J]. INDIAN PEDIATRICS, 2014, 51 (08) : 659 - 660
  • [44] Outcomes of a clinical pathway for primary outpatient management of pediatric patients with low-risk febrile neutropenia
    Paolino, Jonathan
    Mariani, Juliana
    Lucas, Alexandra
    Rupon, Jeremy
    Weinstein, Howard
    Abrams, Annah
    Friedmann, Alison
    [J]. PEDIATRIC BLOOD & CANCER, 2019, 66 (07)
  • [45] Clinical Characteristics and Predictive Factors of Invasive Fungal Disease in Pediatric Oncology Patients with Febrile Neutropenia in a Country with Limited Resources
    Monsereenusorn, Chalinee
    Sricharoen, Thitiyaporn
    Rujkijyanont, Piya
    Suwanpakdee, Detchvijitr
    Photia, Apichat
    Lertvivatpong, Nawachai
    Traivaree, Chanchai
    [J]. PEDIATRIC HEALTH MEDICINE AND THERAPEUTICS, 2021, 12 : 335 - 345
  • [46] Critical appraisal of clinical practice guidelines for adult cancer patients with febrile neutropenia
    Nasr, Ziad G.
    Abu Yousef, Safae
    Jibril, Farah
    Wilby, Kyle J.
    [J]. INTERNATIONAL JOURNAL OF PHARMACY PRACTICE, 2018, 26 (01) : 49 - 54
  • [47] Time to Antibiotics in Pediatric Febrile Neutropenia Patients
    Khan, S.
    Ali, A.
    Sana, S.
    Zia, R.
    Baqari, S.
    Wali, R.
    [J]. PEDIATRIC BLOOD & CANCER, 2017, 64 : S62 - S62
  • [48] Febrile neutropenia in pediatric and adolescent cancer patients
    Bochennek, K.
    Simon, A.
    Laws, H. -J.
    Groll, A. H.
    Lehrnbecher, T.
    [J]. MONATSSCHRIFT KINDERHEILKUNDE, 2021, 169 (05) : 443 - 450
  • [49] Clinical guidelines for the management of neutropenic patients with unexplained fever in Japan: validation by the Japan Febrile Neutropenia Study Group
    Tamura, K
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2005, 26 : S123 - S127
  • [50] Management of febrile neutropenia in immunocompromised patients
    Frassineti, L
    [J]. TUMORI JOURNAL, 2003, : S11 - S13